QIAGEN N.V. (QGEN) Stock Analyst Ratings
USA • New York Stock Exchange • NYSE:QGEN • NL0015002SN0
51.08 USD
+0.3 (+0.59%)
At close: Feb 10, 2026
51.08 USD
0 (0%)
After Hours: 2/10/2026, 8:04:00 PM
ChartMill assigns a Buy % Consensus number of 73% to QGEN. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 54.71. This target is 7.11% above the current price.
- QGEN was analyzed by 24 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about QGEN.
- In the previous month the buy percentage consensus was at a similar level.
- QGEN was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-06 | Stifel | Maintains | Hold -> Hold |
| 2026-02-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-06 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-22 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2025-12-15 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-11 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-26 | B of A Securities | Maintains | Buy -> Buy |
| 2025-06-24 | Barclays | Initiate | Overweight |
| 2025-04-21 | Baird | Maintains | Neutral -> Neutral |
| 2025-04-04 | Redburn Atlantic | Downgrade | Buy -> Neutral |
| 2025-02-19 | Baird | Downgrade | Outperform -> Neutral |
| 2025-02-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-01-06 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-10-17 | HSBC | Downgrade | Buy -> Hold |
| 2024-08-02 | Baird | Maintains | Outperform -> Outperform |
| 2024-06-27 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2024-06-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-01 | Stifel | Maintains | Hold -> Hold |
| 2024-02-16 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-02-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-08 | Citigroup | Maintains | Buy -> Buy |
| 2023-12-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-12-19 | Wells Fargo | Initiate | Equal-Weight |
| 2023-12-13 | Wolfe Research | Initiate | Peer Perform |
| 2023-12-07 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2023-11-02 | UBS | Maintains | Neutral -> Neutral |
| 2023-10-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-09-26 | Citigroup | Reiterate | Buy -> Buy |
QIAGEN N.V. / QGEN FAQ
What do analysts expect the price target to be for QIAGEN N.V. (QGEN)?
24 analysts have analysed QGEN and the average price target is 54.71 USD. This implies a price increase of 7.11% is expected in the next year compared to the current price of 51.08.
Can you provide the consensus rating for QIAGEN N.V. stock?
The consensus rating for QIAGEN N.V. (QGEN) is 72.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for QGEN stock?
The number of analysts covering QIAGEN N.V. (QGEN) is 24.